Madison Radiological Group — Madison, Mississippi

Madison Radiological Group is a clinical research site located in Madison, Mississippi, United States 39110.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Madison Radiological Group has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Hemophilia B.

Sponsors: Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Madison

Browse all research sites in Mississippi · View every site in Madison

• Mississippi Center for Advanced Medicine
• Mississippi Retina Associates
• Madison, MS
• Madison, Mississippi
• Mississippi CTR for ADV MED
• Comprehensive Pain Ctr of
• Mississippi Retina Assoc
• Mississippi Retina Associates /ID# 270934
• Precise Research Center
• Study Center
• Adverum Clinical Site 216
• Mississippi Center Advanced Medicine

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Madison Radiological Group?

Madison Radiological Group has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Madison Radiological Group conducted?

Madison Radiological Group has 1 clinical trials on record, with 1 currently active. Their work covers Hemophilia B.

Is Madison Radiological Group accredited by Crixeo Clinical Trials?

Madison Radiological Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Madison Radiological Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.